ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645253 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645253; 2) Community: the network communities that were significantly associated with the response to NSC 645253; 3) Molecule: the relationships between components within communities and NSC 645253; 4) MDR: the compounds that were significantly associated with the NSC 645253.

NSC Compound Enrichment Correlation
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0352383000003056 0.48504307
NSC 359239 Antibiotic X-14766A 0.0352383000003056 0.00021390934
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0352383000003056 0.43976062
NSC 633514 Null 0.0352383000003056 0.2677961
NSC 637505 Null 0.0352383000003056 0.22085773
NSC 63878 Cytarabine Hydrochloride AZ 0.0352383000003056 0.62358882
NSC 643836 Null 0.0352383000003056 0.11881702
NSC 644622 Null 0.0352383000003056 0.3945727
NSC 645665 Null 0.0352383000003058 0.30403291
NSC 649904 Cyclopentanone, 5-[(4-morpholinyl)methyl]-2-pentylidene-, hydrochloride 0.0352383000003058 0.35149331
Total:103  Current:72    [First] [Prev] [Next] [Last]